Zuckerman Investment Group LLC Sells 254,920 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Zuckerman Investment Group LLC lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 68.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,860 shares of the company's stock after selling 254,920 shares during the period. Zuckerman Investment Group LLC owned 0.10% of Henry Schein worth $8,225,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of HSIC. Lyrical Asset Management LP acquired a new stake in Henry Schein during the 4th quarter worth $126,655,000. Norges Bank purchased a new stake in Henry Schein during the 4th quarter valued at approximately $103,301,000. National Bank of Canada FI grew its stake in shares of Henry Schein by 102.4% in the 4th quarter. National Bank of Canada FI now owns 1,084,511 shares of the company's stock valued at $75,048,000 after purchasing an additional 548,561 shares during the last quarter. Raymond James Financial Inc. purchased a new position in shares of Henry Schein in the 4th quarter valued at approximately $34,720,000. Finally, Clarkston Capital Partners LLC raised its stake in shares of Henry Schein by 24.8% during the fourth quarter. Clarkston Capital Partners LLC now owns 1,744,225 shares of the company's stock worth $120,700,000 after purchasing an additional 346,420 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Henry Schein Stock Down 2.5 %

Henry Schein stock traded down $1.63 during midday trading on Tuesday, hitting $63.98. The stock had a trading volume of 466,395 shares, compared to its average volume of 1,602,145. The stock has a market cap of $7.94 billion, a P/E ratio of 26.33, a P/E/G ratio of 2.13 and a beta of 0.84. The business has a fifty day moving average price of $71.58 and a 200 day moving average price of $72.19. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The company's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.66 EPS. Research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

HSIC has been the topic of a number of analyst reports. Barrington Research reaffirmed an "outperform" rating and issued a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. StockNews.com raised Henry Schein from a "hold" rating to a "buy" rating in a report on Wednesday, April 9th. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. UBS Group reduced their price objective on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Finally, Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research report on Thursday, January 23rd. Five investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Insider Buying and Selling

In related news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total value of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at approximately $4,460,251.20. This represents a 6.05 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Philip A. Laskawy sold 2,604 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the sale, the director now owns 24,805 shares of the company's stock, valued at $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.